Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuh-Pyng Sher

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Theranostics|March 5, 2021
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinomaWei-Chung Cheng, Chun-Yu Chang, Chia-Chien Lo, et al.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Cancer Research|May 11, 2011
Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genesLong-Yuan Li, Hsiuyi Chen, Yi-Hsien Hsieh, et al.
Computational and Structural Biotechnology Journal|September 12, 2022
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinomaChia-Hsin Liu, Shu-Hsuan Liu, Yo-Liang Lai, et al.
International Journal of Biological Sciences|October 21, 2021
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinomaYu-Sen Lin, Ting-Ting Kuo, Chia-Chien Lo, et al.
Blood|December 18, 2012
Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infectionChih-Yu Chi, Chen-Chung Chu, Jing-Pei Liu, et al.
Oncotarget|December 30, 2016
Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasisChi-Che Hsieh, Yi-Ming Shyr, Wen-Ying Liao, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Nature Communications|July 4, 2026
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancerYu Wang, Chao Liu, Song Gao, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Theranostics|March 5, 2021
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinomaWei-Chung Cheng, Chun-Yu Chang, Chia-Chien Lo, et al.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Cancer Research|May 11, 2011
Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genesLong-Yuan Li, Hsiuyi Chen, Yi-Hsien Hsieh, et al.
Computational and Structural Biotechnology Journal|September 12, 2022
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinomaChia-Hsin Liu, Shu-Hsuan Liu, Yo-Liang Lai, et al.
International Journal of Biological Sciences|October 21, 2021
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinomaYu-Sen Lin, Ting-Ting Kuo, Chia-Chien Lo, et al.
Blood|December 18, 2012
Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infectionChih-Yu Chi, Chen-Chung Chu, Jing-Pei Liu, et al.
Oncotarget|December 30, 2016
Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasisChi-Che Hsieh, Yi-Ming Shyr, Wen-Ying Liao, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Nature Communications|July 4, 2026
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancerYu Wang, Chao Liu, Song Gao, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
Pageof 6